Discover undervalued stocks with Eulerpool.

Subscribe for $2

Surgical Science Sweden Stock SUS.ST

Price

88.45
Today +/-
+0.04
Today %
+0.45 %

Surgical Science Sweden stock price

Loading chart...
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Surgical Science Sweden stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Surgical Science Sweden stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Surgical Science Sweden stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Surgical Science Sweden's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Surgical Science Sweden Stock Price History

DateSurgical Science Sweden Price
10/8/202588.45 undefined
10/7/202588.05 undefined
10/6/202590.18 undefined
10/3/202591.45 undefined
10/2/202588.60 undefined
10/1/202588.10 undefined
9/30/202590.25 undefined
9/29/202588.40 undefined
9/26/202589.05 undefined
9/25/202587.00 undefined
9/24/202589.37 undefined
9/23/202590.50 undefined
9/22/202591.70 undefined
9/19/202593.00 undefined
9/18/202589.70 undefined
9/17/202593.65 undefined
9/16/202591.50 undefined
9/15/202592.65 undefined
9/12/202592.60 undefined
9/11/202590.98 undefined
9/10/202592.30 undefined
9/9/202592.75 undefined

Surgical Science Sweden Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Surgical Science Sweden, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Surgical Science Sweden from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Surgical Science Sweden’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Surgical Science Sweden. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Surgical Science Sweden’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Surgical Science Sweden’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Surgical Science Sweden’s growth potential.

Surgical Science Sweden Revenue, EBIT and net profit per share

DateSurgical Science Sweden RevenueSurgical Science Sweden EBITSurgical Science Sweden Net Income
2030e2.75 B undefined0 undefined0 undefined
2029e2.14 B undefined0 undefined0 undefined
2028e1.94 B undefined763.97 M undefined610.7 M undefined
2027e1.54 B undefined459.45 M undefined378.62 M undefined
2026e1.29 B undefined308.25 M undefined256.31 M undefined
2025e1.07 B undefined138.44 M undefined119.56 M undefined
2024884.09 M undefined144.32 M undefined131.65 M undefined
2023882.85 M undefined189.15 M undefined233.97 M undefined
2022802.54 M undefined162.54 M undefined187.97 M undefined
2021366.78 M undefined56.52 M undefined86.25 M undefined
2020104.8 M undefined19.97 M undefined15.61 M undefined
2019101.52 M undefined15.18 M undefined12.6 M undefined
201865.7 M undefined-4.07 M undefined-4.52 M undefined
201757.34 M undefined-4.19 M undefined-2.58 M undefined
201651.84 M undefined-229,700 undefined3.27 M undefined
201546.12 M undefined1.82 M undefined1.62 M undefined
201428.47 M undefined1.5 M undefined1.41 M undefined

Surgical Science Sweden Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M)
NET INCOME (M)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
201420152016201720182019202020212022202320242025e2026e2027e2028e2029e2030e
0.030.050.050.060.070.10.10.370.80.880.881.071.291.541.942.142.75
-64.2910.8711.7614.0455.382.97251.92119.139.980.2321.2720.4318.9026.3810.5228.03
121.43113.04113.73107.0275.3882.1884.6272.4066.2169.3967.5355.6946.2438.8930.7727.8521.75
34525861498388265531612597000000
113-2-412158618723313111925637861000
--200.00-166.67100.00-400.0025.00473.33117.4424.60-43.78-9.16115.1347.6661.38--
2.8614.3214.3219.3224.3229.0534.3742.6750.9150.9451.03000000
- - - - - - - - - - - - - - - - -
Details

Keystats

ⓘ

Revenue and Growth

The Surgical Science Sweden Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Surgical Science Sweden is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (M)
RECEIVABLES (M)
OTHER REC. (M)
INVENTORIES (M)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (B)
TANGIBLE ASSETS (M)
LONG-T. INVEST. (M)
LONG-T. REC. (M)
INTANGIBLE ASSETS (M)
GOODWILL (B)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (B)
TOTAL ASSETS (B)
LIABILITIES
COMMON STOCK (M)
ADDITIONAL PAID-IN CAPITAL (B)
RETAINED EARNINGS (B)
OTHER EQUITY (M)
UNREAL. GAINS/LOSSES (M)
EQUITY (B)
LIABILITIES (M)
PROVISIONS (M)
OTHER SHORT-TERM LIAB. (M)
SHORT-TERM DEBTS (M)
LONG-TERM DEBT PORTION (M)
SHORT-TERM REC. (M)
LONG-T. LIAB. (M)
DEFERRED TAXES (M)
OTHER LIAB. (M)
LONG-T. LIABILITIES (M)
DEBT (M)
TOTAL CAPITAL (B)
20142015201620172018201920202021202220232024
                     
0.12.033.7738.5438.569.2287.16316.68433.73634.37968.16
14.312.9312.928.1512.329.5327.54157.47226.33172.86210.51
2.44.384.172.752.72.944.5422.3217.818.8543.65
3.23.855.948.444.757.1912.46113.11134.88154.45179.58
0.71.660.431.671.573.91.77.3313.6310.6724.11
0.020.020.030.060.060.110.130.620.830.991.43
1.61.51.413.033.639.078.5538.3951.3676.62101.53
000000.210.214.974.374.778.05
0000041.6337.25125.7567.8100
2728.3731.3227.5725.4966.762.9274.03301.02286.57311.91
0000.010.010.260.263.023.443.333.62
003.746.135.686.976.7224.622.1614.8416.33
0.030.030.040.040.040.390.383.493.893.714.05
0.050.050.060.10.10.50.514.14.724.75.48
                     
0.70.720.721.221.221.681.732.542.542.552.55
00.040.040.110.110.420.433.383.383.43.4
-0.02-0.02-0.02-0.02-0.03-0.02-00.20.850.941.43
41.10000000000
00000000000
0.020.020.020.080.080.40.433.594.244.354.83
3.43.5423.643.22.372.334.3765.6941.2958.45
3.43.916.898.677.1714.2714.81104.1844.2747.3458.12
3.42.324.341.95.5322.9514.1781.03180.87133.07377.52
1.53.78.9300000000
000000012.7915.0813.2418.64
11.713.4722.1714.2115.939.5831.28232.38305.91234.94512.72
0004.044.375.534.2912.0714.6840.0256.94
000009.429.6648.5151.514543.55
18.921.619.150000100.1141.0237.537.83
18.921.619.154.044.3714.9613.95160.68107.2122.52138.31
30.635.0741.3118.2420.2854.5445.22393.06413.11357.46651.03
0.050.050.060.10.10.460.473.984.654.75.48
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Surgical Science Sweden provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Surgical Science Sweden's financial health and stability.

Assets

Surgical Science Sweden's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Surgical Science Sweden must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Surgical Science Sweden after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Surgical Science Sweden's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)
DEPRECIATION (M)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (M)
NON-CASH ITEM (M)
PAID INTEREST (M)
PAID TAXES (M)
NET CASH FLOW FROM OPERATING ACTIVITIES (M)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (M)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (M)
NET CHANGE IN EQUITY (B)
CASH FLOW FROM FINANCING ACTIVITIES (B)
CASH FLOW FROM OTHER FINANCING ACTIVITIES ()
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (M)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
201520162017201820192020202120222023
10-4-4151956162189
781010151633510
000000000
050124-14-50-73-11
0000010-1161
000000000
0000093814
71376552339129238
-8-11-8-8-8-8-14-34-44
-8-11-13-8-210-8-2,732-34-44
00-50-2010-2,71800
000000000
20-40-4-5-3117-3
000.0600.190.012.9500.02
000.0400.1902.920.020.02
---19.00------
000000000
113403017229117200
-0.821.74-1.11-1.7646.2914.5324.7194.94194.16
000000000

Surgical Science Sweden stock margins

The Surgical Science Sweden margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Surgical Science Sweden. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Surgical Science Sweden.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Surgical Science Sweden's sales revenue. A higher gross margin percentage indicates that the Surgical Science Sweden retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Surgical Science Sweden's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Surgical Science Sweden's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Surgical Science Sweden's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Surgical Science Sweden. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Surgical Science Sweden's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Surgical Science Sweden Margin History

Surgical Science Sweden Gross marginSurgical Science Sweden Profit marginSurgical Science Sweden EBIT marginSurgical Science Sweden Profit margin
2030e67.63 %0 %0 %
2029e67.63 %0 %0 %
2028e67.63 %39.38 %31.48 %
2027e67.63 %29.93 %24.67 %
2026e67.63 %23.88 %19.85 %
2025e67.63 %12.91 %11.15 %
202467.63 %16.32 %14.89 %
202369.42 %21.43 %26.5 %
202266.23 %20.25 %23.42 %
202172.51 %15.41 %23.52 %
202084.32 %19.06 %14.89 %
201982.33 %14.95 %12.41 %
201874.84 %-6.19 %-6.88 %
2017107.23 %-7.31 %-4.49 %
2016112.2 %-0.44 %6.31 %
2015113.75 %3.95 %3.52 %
2014120.65 %5.27 %4.95 %

Surgical Science Sweden Stock Sales Revenue, EBIT, Earnings per Share

The Surgical Science Sweden earnings per share therefore indicates how much revenue Surgical Science Sweden has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Surgical Science Sweden earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Surgical Science Sweden's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Surgical Science Sweden’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Surgical Science Sweden's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Surgical Science Sweden Revenue, EBIT and net profit per share

DateSurgical Science Sweden Sales per ShareSurgical Science Sweden EBIT per shareSurgical Science Sweden Earnings per Share
2030e53.8 undefined0 undefined0 undefined
2029e42.02 undefined0 undefined0 undefined
2028e38.02 undefined0 undefined11.97 undefined
2027e30.08 undefined0 undefined7.42 undefined
2026e25.3 undefined0 undefined5.02 undefined
2025e21.01 undefined0 undefined2.34 undefined
202417.33 undefined2.83 undefined2.58 undefined
202317.33 undefined3.71 undefined4.59 undefined
202215.76 undefined3.19 undefined3.69 undefined
20218.6 undefined1.32 undefined2.02 undefined
20203.05 undefined0.58 undefined0.45 undefined
20193.49 undefined0.52 undefined0.43 undefined
20182.7 undefined-0.17 undefined-0.19 undefined
20172.97 undefined-0.22 undefined-0.13 undefined
20163.62 undefined-0.02 undefined0.23 undefined
20153.22 undefined0.13 undefined0.11 undefined
20149.95 undefined0.52 undefined0.49 undefined

Surgical Science Sweden business model

Surgical Science Sweden AB is a Swedish company specializing in the development and manufacturing of medical simulators for training professionals in the medical industry. The company was founded in 1999 by a team of doctors, engineers, and scientists and is headquartered in Gothenburg. Since then, the company has constantly expanded and now has several branches around the world, including in the USA, Germany, and Hong Kong. Due to its innovative products and high-quality standards, the company is globally recognized and has received numerous awards. Surgical Science Sweden AB offers a wide range of simulators for various medical disciplines, including surgery, anesthesia, obstetrics, and pediatrics. They offer both hardware and software-based solutions that allow trainees to practice complex procedures and interventions in a safe environment. The company's business model is based on the belief that simulation is crucial for the training of medical professionals to ensure the highest quality and safety for patients. By simulating realistic situations, trainees can gain valuable experience before working in the real practice. Surgical Science Sweden AB has a range of products targeting various areas of medical education. One of their most well-known simulators is the LaparoSculptor, which was specifically developed for training in minimally invasive surgery. The simulator can perform various procedures such as gallbladder and hernia operations, offering both physical and virtual options. Another product is the ObstetricSim, a simulator for obstetric training. The simulator fully simulates the conditions of a normal birth, including the stages of labor and delivery. It also includes rare complications such as shoulder dystocia and umbilical cord prolapse. Surgical Science Sweden AB has also developed simulators focusing on the training of anesthesiologists. The simulator in this area is the ANTS (Anesthesia Simulator), which trains trainees in the proper use of anesthetics, patient observation, and managing emergencies during anesthesia issues. In addition to developing hardware and software solutions, the company also focuses on continuous improvement and development of its products. Surgical Science Sweden AB works closely with leading medical specialists to ensure that the simulator meets the latest requirements and best practices. The company is also willing to rent or sell the simulators and its expertise to medical institutions, providing a broader audience with the opportunity to benefit from the technology. In conclusion, Surgical Science Sweden AB makes a significant contribution to the training of medical professionals and thereby contributes to improving patient health worldwide with its innovative and high-quality simulators. By combining the latest technology, industry expertise, and a constant focus on customer needs, the company continuously strives for excellence and innovation. Surgical Science Sweden is one of the most popular companies on Eulerpool.com.

Surgical Science Sweden SWOT Analysis

Strengths

  • Established presence in the medical simulation industry
  • Strong research and development capabilities
  • High-quality and innovative product portfolio
  • Experienced and knowledgeable management team

Weaknesses

  • Relatively small market share compared to major competitors
  • Limited global distribution network
  • Dependence on third-party suppliers for certain components
  • Higher product prices compared to some competitors

Opportunities

  • Increasing demand for medical simulation solutions
  • Expansion into emerging markets with growing healthcare sectors
  • Collaboration opportunities with renowned medical institutions
  • Development of new simulation technologies

Threats

  • Intense competition from established simulation companies
  • Regulatory challenges in different markets
  • Economic downturn affecting healthcare spending
  • Potential disruptive technologies impacting the industry
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Surgical Science Sweden Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Surgical Science Sweden historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Surgical Science Sweden shares outstanding

The number of shares was Surgical Science Sweden in 2024 — This indicates how many shares 51.026 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Surgical Science Sweden earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Surgical Science Sweden's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Surgical Science Sweden’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Surgical Science Sweden's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Surgical Science Sweden stock splits

In Surgical Science Sweden's history, there have been no stock splits.
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Surgical Science Sweden.

Surgical Science Sweden latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20250.71 -0.39  (-154.64 %)2025 Q2
3/31/20250.53 0.65  (22.57 %)2025 Q1
12/31/20241 0.71  (-29.17 %)2024 Q4
9/30/20240.72 0.84  (16.73 %)2024 Q3
6/30/20240.74 0.56  (-24.82 %)2024 Q2
3/31/20240.88 0.47  (-46.51 %)2024 Q1
12/31/20231.23 1.92  (56.45 %)2023 Q4
9/30/20230.71 0.93  (30.14 %)2023 Q3
6/30/20230.82 0.76  (-7.1 %)2023 Q2
3/31/20230.54 0.98  (82.22 %)2023 Q1
1
2

Surgical Science Sweden shareholders

%
Name
Stocks
Change
Date
13.98962 % Marknadspotential AB7,138,37105/31/2024
11.74365 % Semelin Kapitalförvaltning AB5,992,33805/31/2024
7.56186 % Handelsbanken Kapitalförvaltning AB3,858,528-11,5015/31/2024
6.41070 % Capital Research Global Investors3,271,13705/31/2024
5.61724 % KIRKBI Invest A/S2,866,266315,3055/31/2024
5.57876 % Fjärde AP-Fonden2,846,63070,8775/31/2024
4.33818 % TIN Fonder2,213,60906/30/2025
4.25782 % Carnegie Fonder AB2,172,6022,7996/30/2025
3.21317 % Andra AP-Fonden1,639,5571,639,5575/31/2024
3.04549 % Swedbank Robur Fonder AB1,554,000-80,0006/30/2025
1
2
3
4
5
...
10

Surgical Science Sweden Executives and Management Board

Mr. Gisli Hennermark

(52)
Surgical Science Sweden Director (since 2015)
Compensation 5.22 M

Mr. Roland Bengtsson

(70)
Surgical Science Sweden Chairman of the Board (since 2011)

Mr. Tom Englund

(48)
Surgical Science Sweden Chief Executive Officer

Ms. Anna Ahlberg

(54)
Surgical Science Sweden Chief Financial Officer

Mr. Ran Bronstein

(59)
Surgical Science Sweden President - Research and Development
1
2
3

Most common questions regarding Surgical Science Sweden

What values and corporate philosophy does Surgical Science Sweden represent?

Surgical Science Sweden AB represents a set of core values and corporate philosophy that drive its operations. The company prioritizes excellence in healthcare simulation technology, aiming to enhance medical training and patient safety worldwide. Surgical Science Sweden AB is committed to providing innovative and advanced solutions for surgical education, offering realistic simulators that mimic the human anatomy and empower medical professionals to develop their skills and expertise. With a focus on quality, the company strives for continuous improvement and collaboration with industry partners, ensuring its products are at the forefront of medical simulation. Surgical Science Sweden AB's dedication to delivering superior training tools makes it a trusted leader in the field.

In which countries and regions is Surgical Science Sweden primarily present?

Surgical Science Sweden AB is primarily present in several countries and regions worldwide. The company has a global presence, with a strong focus on Scandinavia, Europe, North America, and Asia. Surgical Science Sweden AB has established partnerships and collaborations with numerous medical institutions, universities, and healthcare providers in these regions, ensuring the widespread availability and adoption of their cutting-edge surgical simulators and training solutions. With their commitment to excellence and innovation, Surgical Science Sweden AB continues to expand its reach, delivering advanced medical training technology to professionals in various countries and regions across the globe.

What significant milestones has the company Surgical Science Sweden achieved?

Surgical Science Sweden AB has achieved significant milestones in its journey. The company has made remarkable advancements in the field of surgical simulation, providing cutting-edge training solutions to medical professionals worldwide. Surgical Science Sweden AB has received recognition for its high-quality simulators, which offer a realistic and immersive experience for trainees. The company's commitment to innovation has led to partnerships with renowned medical institutions, paving the way for research collaborations and improved training methods. Additionally, Surgical Science Sweden AB has expanded its global presence, establishing itself as a leader in surgical education.

What is the history and background of the company Surgical Science Sweden?

Surgical Science Sweden AB is a company with a rich history and background. Established in Sweden, the company has been a prominent player in the field of surgical simulation and training since its inception. With a focus on providing realistic and immersive training solutions for medical professionals, Surgical Science Sweden AB has developed cutting-edge technology and advanced simulators. Over the years, the company has gained recognition for its innovation, quality, and commitment to improving surgical education. With a strong presence in the global market, Surgical Science Sweden AB continues to lead the way in revolutionizing surgical training, ensuring safer and more efficient procedures for healthcare professionals worldwide.

Who are the main competitors of Surgical Science Sweden in the market?

The main competitors of Surgical Science Sweden AB in the market include other companies operating in the medical simulation industry. These competitors may include Simulab Corporation, CAE Healthcare, Mentice AB, and Limbs & Things Ltd. These companies offer similar products and solutions for medical training and simulation purposes, competing with Surgical Science Sweden AB in terms of product quality, pricing, and market share. Surgical Science Sweden AB strives to maintain its competitive edge by continually innovating and delivering high-quality medical simulation technology to its customers.

In which industries is Surgical Science Sweden primarily active?

Surgical Science Sweden AB is primarily active in the healthcare industry.

What is the business model of Surgical Science Sweden?

The business model of Surgical Science Sweden AB revolves around providing advanced medical simulation solutions. As a leading global supplier, Surgical Science focuses on developing and delivering high-fidelity simulators and software tools for medical training and education. These simulation solutions enable medical professionals to practice surgical procedures and enhance their skills in a safe and realistic environment. With a strong commitment to innovation and educational excellence, Surgical Science Sweden AB aims to improve patient safety and quality of care by offering state-of-the-art simulation technology to healthcare institutions and professionals worldwide.

What is the P/E ratio of Surgical Science Sweden 2025?

The Surgical Science Sweden P/E ratio is 37.75.

What is the P/S ratio of Surgical Science Sweden 2025?

The Surgical Science Sweden P/S ratio is 4.21.

What is the Quality Investing of Surgical Science Sweden?

The Quality Investing for Surgical Science Sweden is 6/10.

What is the revenue of Surgical Science Sweden 2025?

The expected Surgical Science Sweden revenue is 1.07 B SEK.

How high is the profit of Surgical Science Sweden 2025?

The expected Surgical Science Sweden profit is 119.56 M SEK.

What is the business model of Surgical Science Sweden

The company Surgical Science Sweden AB is an innovative company in the field of medical education. Founded in 1999, the company aims to improve the training of medical personnel by producing realistic simulators. The company places great emphasis on attention to detail and realistic simulation in order to ensure a high training quality. Surgical Science Sweden AB's business model is based on three areas of business: 1. Medical simulators Surgical Science Sweden AB produces a wide range of medical simulators that support the training of medical personnel in various areas. These include simulators for endovascular procedures, minimally invasive procedures, anesthesia, and resuscitation. The simulators are designed to be realistic and equipped with various scenarios to provide an effective training experience. 2. Training programs In addition to manufacturing medical simulators, Surgical Science Sweden AB also offers training programs tailored to the respective simulators. The training is provided by experienced instructors who support trainees in working with the simulators and provide feedback on their training. These training programs are an effective way to bring medical personnel up to date with the latest technology or acquire specific skills. 3. Maintenance and support Surgical Science Sweden AB also offers maintenance and support services for its medical simulators. These services are important to ensure that the simulators are always in perfect condition and ready for use at any time. In addition, the company also offers training in the use of the simulators and first-class technical support. Overall, Surgical Science Sweden AB has developed an innovative business model based on the production of realistic medical simulators, while also enabling high-quality training for medical personnel. The company has achieved its market position through a consistent focus on quality and innovation. The simulators from Surgical Science Sweden AB are used in leading medical training institutions worldwide, contributing to the improvement of medical personnel training and patient safety.

What is the Surgical Science Sweden dividend?

Surgical Science Sweden pays a dividend of 0 SEK distributed over payouts per year.

How often does Surgical Science Sweden pay dividends?

The dividend cannot currently be calculated for Surgical Science Sweden or the company does not pay out a dividend.

What is the Surgical Science Sweden ISIN?

The ISIN of Surgical Science Sweden is SE0014428512.

What is the Surgical Science Sweden WKN?

The WKN of Surgical Science Sweden is A2P46G.

What is the Surgical Science Sweden ticker?

The ticker of Surgical Science Sweden is SUS.ST.

How much dividend does Surgical Science Sweden pay?

Over the past 12 months, Surgical Science Sweden paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Surgical Science Sweden is expected to pay a dividend of 0 SEK.

What is the dividend yield of Surgical Science Sweden?

The current dividend yield of Surgical Science Sweden is .

When does Surgical Science Sweden pay dividends?

Surgical Science Sweden pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Surgical Science Sweden?

Surgical Science Sweden paid dividends every year for the past 0 years.

What is the dividend of Surgical Science Sweden?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Surgical Science Sweden located?

Surgical Science Sweden is assigned to the 'Health' sector.

Wann musste ich die Aktien von Surgical Science Sweden kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Surgical Science Sweden from 10/8/2025 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 10/8/2025.

When did Surgical Science Sweden pay the last dividend?

The last dividend was paid out on 10/8/2025.

What was the dividend of Surgical Science Sweden in the year 2024?

In the year 2024, Surgical Science Sweden distributed 0 SEK as dividends.

In which currency does Surgical Science Sweden pay out the dividend?

The dividends of Surgical Science Sweden are distributed in SEK.

All fundamentals about Surgical Science Sweden

Our stock analysis for Surgical Science Sweden Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Surgical Science Sweden Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.